The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extracts

Annals of Allergy, Asthma and Immunology

Volumn 103, Issue 1, 2009, Pages 57-61

  Bilò, M Beatrice ^a   Severino, Maurizio ^b   Cilia, Marcello ^c   Pio, Antonio ^d   Casino, Giuseppe ^e   Ferrarini, Ettore ^f   Campodonico, Patrizia ^g   Milani, Massimo ^g  

^a OSPEDALI RIUNITI   (Italy)

^b Ospedale San Giovanni di Dio   (Italy)

^c Allergy Clinic   (Italy)

^d Ospedale Curteri   (Italy)

^e Allergy and Respiratory Operative Unit   (Italy)

^f Osp Umberto I   (Italy)

^g Medical Department   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLPYRAL; BEE VENOM; IMMUNOGLOBULIN E;

ALLERGY; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; EPIGASTRIC PAIN; FEMALE; HONEYBEE VENOM ALLERGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; URTICARIA; YELLOW JACKET VENOM ALLERGY;

EID: 67650388098     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60144-5     Document Type: Article

References (14)

1. Bonifazi F, Jutel M, Bilo BM, Birnbaum J, Muller U, Bucher C. Prevention and treatment of Hymenoptera venom allergy: guidelines for clinical practice. Allergy. 2005;60:1459-1470. (Pubitemid 41654315)
2. Lockey RF, Turkeltaub PC, Olive ES, et al. The Hymenoptera venom study, III: safety of venom immunotherapy. J Allergy Clin Immunol. 1990;86:775-780.
3. Mosbech H, Muller U; European Academy of Allergology and Clinical Immunology. Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. Allergy. 2000;55:1005-1010.
4. Muller UR, Golden DB, Demarco PJ, et al. Immunotherapy for Hymenoptera venom and biting insect hypersensitivity. Clin Allergy Immunol. 2004;18:541-559.
5. Rueff F, Wolf H, Schnitker J, et al. Specific immunotherapy honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. Allergy. 2004;59:589-595. (Pubitemid 38748057)
6. Quercia O, Emiliani F, Pecora S, Burastero S, Stefanini G. Efficacy, safety, and modulation of immunologic markers by immunotherapy with honeybee venom: comparison of standardized quality depot versus aqueous extract. Allergy Asthma Proc. 2006;27:151-158.
7. Golden DBK, Kelly D. Dialyzed venom skin tests for identifying yellow jacket-allergic patients not detected using standard venom. Ann Allergy Asthma Immunol. 2009;102:47-50.
8. Mueller HL. Diagnosis and treatment of insect sensitivity. J Asthma Res. 1966;3:331-333.
9. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Ann Intern Med. 1997;126:712-720. (Pubitemid 27184043)
10. Cadario G, Marengo F, Ranghino E, et al. Higher frequency of early local side effects with aqueous versus depot immunotherapy for Hymenoptera venom allergy. J Investig Allergol Clin Immunol. 2004;14:1-7. (Pubitemid 38987684)
11. Birnbaum J, Charpin D, Vervloet D. Rapid Hymenoptera venom immunotherapy:comparative safety of three protocols. Clin Exp Allergy. 1993;23:331-333. (Pubitemid 23112346)
12. Mosbech H, Malling HJ, Biering I. Immunotherapy with yellow jacket venom: a comparative study including three different extracts, one adsorbed to aluminium hydroxide and two unmodified. Allergy. 1986; 41:95-103. (Pubitemid 16044349)
13. Alessandrini A. Berra D, Lodi Rizzini F. Flexible approaches in the design of subcutaneous immunotherapy protocols for hymenoptera venom allergy. Ann Allergy Asthma Immunol. 2006;97:92-97. (Pubitemid 44156344)
14. Mueller U. Insect Sting Allergy. Jena, Germany: Gustav Fischer Verlag; 1990.